Reversible MR Changes in the Cat Brain after Cerebral Fat Embolism Induced by Triolein Emulsion

References

1. ↵
   Sevitt S. The significance and pathology of fat embolism. Ann Clin Res 1977;9:173–180

   PubMedWeb of Science
2. Chrysikopoulos H, Maniatis V, Pappas J, Filalithis P, Gogali C, Sfyras D. Case report: post-traumatic cerebral fat embolism: CT and MR findings—report of two cases and review of the literature. Clin Radiol 1996;51:728–732

   PubMed
3. ↵
   Saito A, Meguro K, Matsumura A, Komatsu Y, Oohashi N. Magnetic resonance imaging of a fat embolism of the brain: case report. Neurosurgery 1990;26:882–885

   PubMed
4. ↵
   Kim HJ, Lee JH, Lee CH, et al. Experimental cerebral fat embolism: embolic effects of triolein and oleic acid depicted by MR imaging and electron microscopy. AJNR Am J Neuroradiol 2002;23:1516–1523

   Abstract/FREE Full Text
5. ↵
   Kim HJ, Lee CH, Lee SH, Moon TY. Magnetic resonance imaging and histologic findings of experimental cerebral fat embolism. Invest Radiol 2003;38:625–634

   PubMedWeb of Science
6. ↵
   Kim HJ, Lee CH, Lee SH, et al. Early development of vasogenic edema in experimental cerebral fat embolism in cat. Invest Radiol 2001;36:460–469

   CrossRefPubMed
7. ↵
   Abbott NJ, Romero IA. Transporting therapeutics across the blood-brain barrier. Mol Med Today 1996;2:106–113

   CrossRefPubMedWeb of Science
8. ↵
   Peltier LF. Fat embolism, III: the toxic properties of neutral fat and free fatty acids. Surgery 1956;40:665–670

   PubMedWeb of Science
9. Peltier LF. Fat embolism. A current concept. Clin Orthop 1969;66:241–253

   PubMed
10. Moylan JA, Birnbaum M, Katz A, Everson MA. Fat emboli syndrome. J Trauma 1976;16:341–347

    PubMed
11. ↵
    Gossling HR, Pellegrini VD Jr. Fat embolism syndrome: a review of the pathophysiology and physiological basis of treatment. Clin Orthop 1982;165:68–82
12. ↵
    Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998;42:1083–1100

    CrossRefPubMedWeb of Science
13. Nilaver G, Muldoon LL, Kroll RA, et al. Delivery of herpes virus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci U S A 1995;92:9829–9833

    Abstract/FREE Full Text
14. Doran SE, Ren XD, Betz AL, et al. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Experimental study. Neurosurgery 1995;36:965–970

    PubMedWeb of Science
15. ↵
    McAllister LD, Doolittle ND, Guastadisegni PE, et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 2000;46:51–61

    CrossRefPubMedWeb of Science
16. ↵
    Gumerlock MK, Neuwelt EA. Therapeutic opening of the blood-brain barrier in man. In: Bradbury MWB, ed. The Physiology of the Blood-Brain Barrier. Heidelberg: Springer-Verlag;1992 :525–542
17. ↵
    Nomura T, Inamura T, Black KL. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res 1994;659:62–66

    CrossRefPubMedWeb of Science
18. ↵
    Black KL, King WA, Ikezaki K. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4. J Neurosurg 1990;72:912–916

    PubMed